Patients who need stem cell or cord blood transplants could keep using the national matching system for five more years. The bill extends existing programs through 2031 and sets the main transplant program at $33,009,000 a year from 2027 to 2031.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Stem Cell Therapeutic and Research Reauthorization Act of 2025 is a House bill waiting for floor action. The latest recorded action: Placed on the Union Calendar, Calendar No. 629.
Latest action on H.R. 5160: Placed on the Union Calendar, Calendar No. 629.
Who this affects: This bill mainly affects people who need stem cell or cord blood transplants and the groups that help them get those cells. The biggest direct effect falls on patients searching for a match, along with hospitals, transplant centers, donors, and cord blood banks that take part in the national system. Researchers and public health programs tied to these efforts could also be affected because the bill keeps the current legal authority and funding structure in place.
Why this matters: This matters because some very sick patients depend on these programs to find transplant matches. If Congress did not extend the law, parts of the current system could lose federal authority or support after the dates in current law. The bill also raises the authorized funding for the main transplant program for future years, which could help the system keep operating as costs rise. But the bill does not say exactly how much real-world impact those funding levels would have.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
